Position in GLAS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,820
New position
Shares Held
140
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $41,172 across 9 Drug Manufacturers - Specialty & Generic names. GLAS ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
386 | $27,737 | |
| 2 | VTRS |
Viatris Inc
|
225 | $3,573 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
177 | $2,837 | |
| 4 | HLN |
Haleon plc
|
219 | $2,043 | |
| 5 | GLAS |
Glass House Brands Inc.
This page
|
140 | $1,820 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
43 | $1,456 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6 | $1,011 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
28 | $689 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,820 | 140 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||